NO154841C - Analogifremgangsmaate for fremstilling av farmakologisk aktive karbo styrilderivater. - Google Patents
Analogifremgangsmaate for fremstilling av farmakologisk aktive karbo styrilderivater.Info
- Publication number
- NO154841C NO154841C NO802762A NO802762A NO154841C NO 154841 C NO154841 C NO 154841C NO 802762 A NO802762 A NO 802762A NO 802762 A NO802762 A NO 802762A NO 154841 C NO154841 C NO 154841C
- Authority
- NO
- Norway
- Prior art keywords
- styric
- derivatives
- preparation
- pharmacologically active
- analogue procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12045279A JPS5643280A (en) | 1979-09-18 | 1979-09-18 | Carbostyril derivative |
| JP12556579A JPS5649360A (en) | 1979-09-28 | 1979-09-28 | 2-oxoquinoline derivative |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO802762L NO802762L (no) | 1981-03-19 |
| NO154841B NO154841B (no) | 1986-09-22 |
| NO154841C true NO154841C (no) | 1987-01-07 |
Family
ID=26458032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO802762A NO154841C (no) | 1979-09-18 | 1980-09-17 | Analogifremgangsmaate for fremstilling av farmakologisk aktive karbo styrilderivater. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4482560A (xx) |
| AR (2) | AR230280A1 (xx) |
| AT (1) | AT376972B (xx) |
| AU (1) | AU518144B2 (xx) |
| CA (1) | CA1151172A (xx) |
| CH (1) | CH645892A5 (xx) |
| DE (1) | DE3034237A1 (xx) |
| DK (1) | DK158984C (xx) |
| ES (1) | ES8200679A1 (xx) |
| FI (1) | FI76322C (xx) |
| FR (1) | FR2465732A1 (xx) |
| GB (1) | GB2063869B (xx) |
| IT (1) | IT1129263B (xx) |
| MX (1) | MX6806E (xx) |
| NL (1) | NL187912C (xx) |
| NO (1) | NO154841C (xx) |
| PT (1) | PT71810B (xx) |
| SE (1) | SE439632B (xx) |
| SU (1) | SU1091857A3 (xx) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2901336A1 (de) | 1979-01-15 | 1980-07-24 | Boehringer Mannheim Gmbh | Neue arylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
| CH655110A5 (de) * | 1982-09-03 | 1986-03-27 | Otsuka Pharma Co Ltd | Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten. |
| GB8426584D0 (en) * | 1984-10-19 | 1984-11-28 | Beecham Group Plc | Compounds |
| US4704390A (en) * | 1986-02-13 | 1987-11-03 | Warner-Lambert Company | Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents |
| US4792561A (en) * | 1986-05-29 | 1988-12-20 | Syntex (U.S.A.) Inc. | Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors |
| US4921862A (en) * | 1986-05-29 | 1990-05-01 | Syntex (U.S.A.) Inc. | Carbostyril derivatives as combined thromboxane synthetase and cyclic-amp phosphodiesterase inhibitors |
| DK397387A (da) * | 1986-07-31 | 1988-02-01 | Otsuka Pharma Co Ltd | Carbostyrilderivater og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser |
| FR2620704B1 (fr) * | 1987-09-17 | 1991-04-26 | Sanofi Sa | Derives de (benzyl-4 piperidino)-1 propanol-2, leur preparation, leur utilisation comme antimicrobiens et les produits les contenant |
| US5227381A (en) * | 1988-05-02 | 1993-07-13 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivative |
| US5082847A (en) * | 1990-07-18 | 1992-01-21 | Syntex (U.S.A.) Inc. | Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility |
| JP2686887B2 (ja) * | 1992-08-11 | 1997-12-08 | キッセイ薬品工業株式会社 | ピペリジノ−３，４−ジヒドロカルボスチリル誘導体 |
| IT1264816B1 (it) * | 1993-07-28 | 1996-10-10 | Pergam Srl | Procedimento per la preparazione di derivati del procedimento per la preparazione di derivati del 3,4-diidrocarbostirile 3,4-diidrocarbostirile |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610736B (en) | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
| ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
| WO2001087834A1 (fr) * | 2000-05-16 | 2001-11-22 | Takeda Chemical Industries, Ltd. | Antagoniste de l'hormone de concentration de la melanine |
| BR0305500A (pt) † | 2003-01-09 | 2004-11-03 | Otsuka Pharma Co Ltd | Processo para preparar aripiprazol |
| DE102008022221A1 (de) | 2008-05-06 | 2009-11-12 | Universität des Saarlandes | Inhibitoren der humanen Aldosteronsynthase CYP11B2 |
| US8541404B2 (en) | 2009-11-09 | 2013-09-24 | Elexopharm Gmbh | Inhibitors of the human aldosterone synthase CYP11B2 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3629266A (en) * | 1969-03-03 | 1971-12-21 | Miles Lab | (phenyl piperidino alkyl)3 4-dihydrocarbostyrils |
| JPS517672B2 (xx) * | 1972-04-13 | 1976-03-10 | ||
| US3910924A (en) * | 1972-04-13 | 1975-10-07 | Otsuka Pharma Co Ltd | 3,4-Dihydrocarbostyril derivatives and a process for preparing the same |
| US4256890A (en) * | 1972-09-14 | 1981-03-17 | Otsukapharmaceutical Co., Ltd. | 3,4-Dihydrocarbostyril derivatives and process for producing the same |
| JPS5239035B2 (xx) * | 1972-12-14 | 1977-10-03 | ||
| JPS5310986B2 (xx) * | 1974-02-05 | 1978-04-18 | ||
| JPS5310989B2 (xx) * | 1974-04-25 | 1978-04-18 | ||
| US3994900A (en) * | 1976-01-23 | 1976-11-30 | E. R. Squibb & Sons, Inc. | 6-(Or 8)-[[(substituted amino)alkyl]oxy(or thio)]-3,4-dihydro-4-phenyl-2(1H)-quinolinones |
| US4210753A (en) * | 1976-03-17 | 1980-07-01 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril compounds |
| CH619453A5 (xx) * | 1976-03-17 | 1980-09-30 | Otsuka Pharma Co Ltd | |
| JPS609501B2 (ja) * | 1976-05-07 | 1985-03-11 | 大塚製薬株式会社 | 新規３，４−ジヒドロカルボスチリル誘導体 |
| JPS5919541B2 (ja) * | 1976-03-17 | 1984-05-07 | 大塚製薬株式会社 | 新規３，４−ジヒドロカルボスチリル誘導体 |
| DE2719562C2 (de) * | 1976-05-08 | 1986-05-07 | Otsuka Pharmaceutical Co. Ltd., Tokio/Tokyo | 3, 4-Dihydrocarbostyrilderivate, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten |
| JPS6019295B2 (ja) * | 1977-03-04 | 1985-05-15 | 大塚製薬株式会社 | カルボスチリル誘導体及びその製造法 |
| JPS5416478A (en) * | 1977-07-08 | 1979-02-07 | Otsuka Pharmaceut Co Ltd | 3,4-dihydrocarbostyril herivative |
| JPS54130587A (en) * | 1978-03-30 | 1979-10-09 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
| DE2827566A1 (de) * | 1978-06-23 | 1980-01-10 | Boehringer Mannheim Gmbh | 1,2-dihydro-chinolin-2-on-derivate und verfahren zu ihrer herstellung |
| JPS5589221A (en) * | 1978-12-28 | 1980-07-05 | Otsuka Pharmaceut Co Ltd | Antihistaminic agent |
| JPS5589222A (en) * | 1978-12-28 | 1980-07-05 | Otsuka Pharmaceut Co Ltd | Antihistaminic agent |
| DE2901336A1 (de) * | 1979-01-15 | 1980-07-24 | Boehringer Mannheim Gmbh | Neue arylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
-
1980
- 1980-09-11 DE DE19803034237 patent/DE3034237A1/de active Granted
- 1980-09-12 AU AU62381/80A patent/AU518144B2/en not_active Ceased
- 1980-09-12 FR FR8019708A patent/FR2465732A1/fr active Granted
- 1980-09-16 SU SU802982853A patent/SU1091857A3/ru active
- 1980-09-16 FI FI802905A patent/FI76322C/fi not_active IP Right Cessation
- 1980-09-17 DK DK394080A patent/DK158984C/da active
- 1980-09-17 AT AT0465780A patent/AT376972B/de not_active IP Right Cessation
- 1980-09-17 PT PT71810A patent/PT71810B/pt unknown
- 1980-09-17 AR AR282565A patent/AR230280A1/es active
- 1980-09-17 CA CA000360402A patent/CA1151172A/en not_active Expired
- 1980-09-17 CH CH694080A patent/CH645892A5/de not_active IP Right Cessation
- 1980-09-17 NL NLAANVRAGE8005188,A patent/NL187912C/xx not_active IP Right Cessation
- 1980-09-17 SE SE8006498A patent/SE439632B/sv not_active IP Right Cessation
- 1980-09-17 NO NO802762A patent/NO154841C/no unknown
- 1980-09-18 MX MX809034U patent/MX6806E/es unknown
- 1980-09-18 GB GB8030207A patent/GB2063869B/en not_active Expired
- 1980-09-18 IT IT68445/80A patent/IT1129263B/it active
- 1980-09-18 ES ES495163A patent/ES8200679A1/es not_active Expired
-
1982
- 1982-03-12 US US06/357,769 patent/US4482560A/en not_active Expired - Fee Related
- 1982-05-18 AR AR289431A patent/AR230059A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| AT376972B (de) | 1985-01-25 |
| DE3034237A1 (de) | 1981-04-16 |
| IT1129263B (it) | 1986-06-04 |
| FI76322C (fi) | 1988-10-10 |
| FI76322B (fi) | 1988-06-30 |
| PT71810B (en) | 1981-07-07 |
| FI802905A (fi) | 1981-03-19 |
| NL8005188A (nl) | 1981-03-20 |
| FR2465732A1 (fr) | 1981-03-27 |
| NL187912B (nl) | 1991-09-16 |
| SU1091857A3 (ru) | 1984-05-07 |
| NO802762L (no) | 1981-03-19 |
| DK158984B (da) | 1990-08-13 |
| GB2063869B (en) | 1983-05-25 |
| CH645892A5 (de) | 1984-10-31 |
| AU6238180A (en) | 1981-05-28 |
| AR230280A1 (es) | 1984-03-01 |
| CA1151172A (en) | 1983-08-02 |
| ATA465780A (de) | 1984-06-15 |
| US4482560A (en) | 1984-11-13 |
| GB2063869A (en) | 1981-06-10 |
| NO154841B (no) | 1986-09-22 |
| ES495163A0 (es) | 1981-11-16 |
| SE8006498L (sv) | 1981-03-19 |
| DK394080A (da) | 1981-03-19 |
| AU518144B2 (en) | 1981-09-17 |
| DK158984C (da) | 1991-01-14 |
| ES8200679A1 (es) | 1981-11-16 |
| FR2465732B1 (xx) | 1983-06-24 |
| MX6806E (es) | 1986-07-30 |
| PT71810A (en) | 1980-10-01 |
| IT8068445A0 (it) | 1980-09-18 |
| SE439632B (sv) | 1985-06-24 |
| NL187912C (nl) | 1992-02-17 |
| DE3034237C2 (xx) | 1988-04-21 |
| AR230059A1 (es) | 1984-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO151362C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive urinstoffderivater. | |
| NO800626L (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive polyolderivater | |
| NO155774C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater. | |
| NO153177C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater. | |
| NO159019C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive 6beta-hydroksyalkylpenicillansyrederivater. | |
| NO145657C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive alkenderivater. | |
| NO159016C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater. | |
| NO156785C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater. | |
| NO154918C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. | |
| NO821645L (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive benzoazepinderivater | |
| NO142034C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoletere. | |
| NO149035C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive acylanilid-derivater | |
| NO155055C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater. | |
| NO154058C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-heterocyklyl-4-piperidinaminer. | |
| NO148813C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater | |
| NO154841C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive karbo styrilderivater. | |
| NO780883L (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive 4-acylamino-fenyl-etanolaminer | |
| NO802015L (no) | Fremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater. | |
| NO157503C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive azepinderivater. | |
| NO147986C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive fenyletylaminer | |
| NO781878L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner. | |
| NO160370C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser. | |
| NO159090C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater. | |
| NO147483C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner. | |
| NO145950C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive homoftalimider |